Tag: Certification from NY State,NSCLC,Non-Small Cell Lung Cancer,Press Releases,Veristrat,blood-based cancer test,liquid biopsy,lung cancer,oncology,personalized medicine,serum protein test

Biodesix, Inc., a fully integrated molecular diagnostics company advancing the development of products for personalized medicine, today announced that they have received the clinical laboratory evaluation program certification from the New York State Department of Health’s Wadsworth Center. With this certification, VeriStrat®, a serum proteomic test to help physicians guide treatment for patients with non-small cell…